These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29745270)

  • 1. QSAR modelling: a therapeutic patent review 2010-present.
    Halder AK; Moura AS; Cordeiro MNDS
    Expert Opin Ther Pat; 2018 Jun; 28(6):467-476. PubMed ID: 29745270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET inhibitors in cancer therapeutics: a patent review.
    Ghoshal A; Yugandhar D; Srivastava AK
    Expert Opin Ther Pat; 2016; 26(4):505-22. PubMed ID: 26924192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
    Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
    Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacological modulators of autophagy: an updated patent review (2012-2015).
    Ha J; Kim J
    Expert Opin Ther Pat; 2016 Nov; 26(11):1273-1289. PubMed ID: 27476990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part II: curcumin derivatives in cancer and neurodegeneration.
    Di Martino RMC; Bisi A; Rampa A; Gobbi S; Belluti F
    Expert Opin Ther Pat; 2017 Aug; 27(8):953-965. PubMed ID: 28597702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state on tryptophan 2,3-dioxygenase inhibitors: a patent review.
    Kozlova A; Frédérick R
    Expert Opin Ther Pat; 2019 Jan; 29(1):11-23. PubMed ID: 30526149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR studies in the discovery of novel type-II diabetic therapies.
    Abuhammad A; Taha MO
    Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
    Tandon VK; Kumar S
    Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
    Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Studies in Drug Research Against Neurodegenerative Diseases.
    Makhouri FR; Ghasemi JB
    Curr Neuropharmacol; 2018; 16(6):664-725. PubMed ID: 28831921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in quantitative structure-activity relationship models of anti-Alzheimer's agents.
    Ambure P; Roy K
    Expert Opin Drug Discov; 2014 Jun; 9(6):697-723. PubMed ID: 24754675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010 - 2015; part 2).
    Kim T; Pae AN
    Expert Opin Ther Pat; 2016 Nov; 26(11):1353-1366. PubMed ID: 27599163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).
    Lajarín-Cuesta R; Arribas RL; De Los Ríos C
    Expert Opin Ther Pat; 2016; 26(3):389-407. PubMed ID: 26853448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sigma receptor modulators: a patent review.
    Collina S; Gaggeri R; Marra A; Bassi A; Negrinotti S; Negri F; Rossi D
    Expert Opin Ther Pat; 2013 May; 23(5):597-613. PubMed ID: 23387851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAO inhibitors and their wider applications: a patent review.
    Carradori S; Secci D; Petzer JP
    Expert Opin Ther Pat; 2018 Mar; 28(3):211-226. PubMed ID: 29324067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.
    Serafino A; Sferrazza G; Colini Baldeschi A; Nicotera G; Andreola F; Pittaluga E; Pierimarchi P
    Expert Opin Drug Discov; 2017 Feb; 12(2):169-186. PubMed ID: 27960558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
    Abdizadeh T; Ghodsi R; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings.
    Nandekar PP; Sangamwar AT
    Expert Opin Drug Discov; 2012 Sep; 7(9):771-89. PubMed ID: 22716293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
    Marzaro G; Guiotto A; Chilin A
    Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.